Browsing tag:


High Quality APIs For503B Outsourcing Facilities

Erlanger, Kentucky, June 24, 2019 – LGM Pharma, LLC, a leader in Active Pharmaceutical Ingredient (API) sourcing, distribution and supply chain management to the pharmaceutical and biotechnology industries, today reported that it is offering an expanded set of value-added services to support its clients who supply APIs to compounding pharmacies under section 503B of the[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service